title: A new recombinant factor VIII: from genetics to clinical use.
authors.affiliation: Octapharma Biopharmaceuticals GmbH, Molecular Biochemistry, Berlin, Germany.
authors.forename: Christoph
authors.initials: C
authors.lastname: Kannicht
authors.affiliation: Octapharma Biopharmaceuticals GmbH, Molecular Biochemistry, Berlin, Germany.
authors.forename: Guido
authors.initials: G
authors.lastname: Kohla
authors.affiliation: Octapharma Biopharmaceuticals GmbH, Heidelberg, Germany.
authors.forename: Maya
authors.initials: M
authors.lastname: Tiemeyer
authors.affiliation: Octapharma AG, Lachen, Switzerland.
authors.forename: Olaf
authors.initials: O
authors.lastname: Walter
authors.affiliation: CoaBio AB, Bromma, Sweden.
authors.forename: Helena
authors.initials: H
authors.lastname: Sandberg
mesh_terms: D000818:Animals; D005169:Factor VIII / Q000235:genetics* / Q000627:therapeutic use*; D006467:Hemophilia A / Q000628:therapy*; D006801:Humans
chemical_list: D005169:Factor VIII